357 related articles for article (PubMed ID: 17070369)
1. Renal ultrasound studies after endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
Yu RN; Jones EA; Roth DR
Urology; 2006 Oct; 68(4):866-8; discussion 868-9. PubMed ID: 17070369
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
[TBL] [Abstract][Full Text] [Related]
5. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
6. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
Puri P; Kutasy B; Colhoun E; Hunziker M
J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
Friedmacher F; Colhoun E; Puri P
J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
[TBL] [Abstract][Full Text] [Related]
8. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy?
Zamilpa I; Koyle MA; Grady RW; Joyner BD; Shnorhavorian M; Lendvay TS
J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
[TBL] [Abstract][Full Text] [Related]
10. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
Ozok U; Eroglu M; Imamoglu A; Bakirtaş H; Güvence N; Kiper A
J Endourol; 2005 Dec; 19(10):1185-7. PubMed ID: 16359211
[TBL] [Abstract][Full Text] [Related]
11. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
[TBL] [Abstract][Full Text] [Related]
13. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
Palmer LS
J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters.
Molitierno JA; Scherz HC; Kirsch AJ
J Pediatr Urol; 2008 Oct; 4(5):372-6. PubMed ID: 18790423
[TBL] [Abstract][Full Text] [Related]
15. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Subureteral Endoscopic Injection of Dextranomer/Hyaluronic Acid and Lich-Gregoir Ureteral Reimplantation in the Treatment of Pediatric Primary Vesicoureteral Reflux: A Prospective Randomized Study.
Salih EM; Eldamanhory H; Selmy GI; Galal HA
J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):719-723. PubMed ID: 33751917
[No Abstract] [Full Text] [Related]
17. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
Stenberg A; Larsson E; Läckgren G
J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
[TBL] [Abstract][Full Text] [Related]
19. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
